Stocks · Healthcare · Biotechnology
Precigen, Inc. PGEN
$7.74 -9.37% Close, Oct 5, 2026 · NASDAQ · Market cap $3.04B
Strong growthStrong trend
Next earnings report: Nov 12, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Revenue over the last four quarters was $85.7M, up 1875.0% from a year earlier, accelerating from 652.1% a quarter earlier.
- Operating margin widened to -46.1% from -2399.5% a year earlier.
- The diluted share count rose 39.6% in a year.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 6, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 2%
- Revenue growth, 3-year CAGRBottom 6%
- Revenue growth accelerationTop 1%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 44%
- Gross marginTop 19%
- Operating marginBottom 35%
- Accruals (lower is better)Top 8%
- Interest coverBottom 43%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 39%
- Free-cash-flow yieldTop 48%
- EBITDA / enterprise valueBottom 50%
- Sales / enterprise valueBottom 14%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 14%
- 6-month returnTop 12%
- 1-year return vs S&P 500Top 10%
- Distance from 52-week highTop 23%
- Trend checklist (0–4)Top 10%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 5%
- Consecutive EPS beatsTop 25%
- Share of analysts rating BuyBottom 37%
- Upside to consensus price targetTop 29%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 40%
- Maximum drawdown, 3 yearsTop 41%
- Beta vs S&P 500 (lower is better)Bottom 30%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 652.1% | 1875.0% | ↑ |
| Gross margin | -18.7% | 89.6% | ↑ |
| Operating margin | -2399.5% | -46.1% | ↑ |
| FCF margin | -1607.7% | -135.1% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 1875.0% | 652.1% | ↑ | Top 2% |
| Gross margin | 89.6% | -18.7% | ↑ | Top 19% |
| Operating margin | -46.1% | -2399.5% | ↑ | Bottom 35% |
| Net margin | -184.0% | -2868.7% | ↑ | — |
| Free-cash-flow margin | -135.1% | -1607.7% | ↑ | — |
| Return on invested capital | -27.8% | — | Bottom 44% | |
| Revenue growth, 3-year CAGR | -28.9% | — | Bottom 6% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -25.6%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 15.3%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +10642.1 pp
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -4.1×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -0.03%
- Shareholder yield
- -0.03%
- Share count change, 1 year
- +39.6%
- Share count change, 3-year CAGR
- +18.6%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 4, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 3
- Beats in the last 8 reports
- 4 of 8
- Average EPS surprise, last 4
- -100.0%
- Average 2-day reaction, last 8
- -0.3%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $18.00
- Target vs current price
- +132.6%
- Analysts with a rating
- 16
- Share rating Buy or Strong Buy
- 69%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 4, 2026 | +514.3% | -1.2% | +5.9% | +4.8% | — |
| May 13, 2026 | +33.3% | +1.7% | +2.0% | -4.7% | +77.2% |
| Mar 25, 2026 | +33.6% | -1.0% | +23.6% | +26.5% | +54.0% |
| Nov 13, 2025 | -1225.0% | -4.0% | +5.0% | -10.0% | +15.9% |
| Aug 12, 2025 | -26.9% | +3.4% | +69.5% | +137.4% | +123.0% |
| May 14, 2025 | -125.0% | -5.2% | +4.4% | +11.1% | +31.9% |
| Mar 19, 2025 | +33.3% | +7.2% | +2.4% | -13.8% | -9.0% |
| Nov 14, 2024 | -12.5% | -3.6% | -8.6% | -22.2% | +108.6% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 4, 2026 | $0.05 | -$0.01 | +514.3% | $55.0M |
| May 13, 2026 | -$0.02 | -$0.03 | +33.3% | $23.3M |
| Mar 25, 2026 | -$0.07 | -$0.10 | +33.6% | $4.6M |
| Nov 13, 2025 | -$1.06 | -$0.08 | -1225.0% | $2.9M |
| Aug 12, 2025 | -$0.11 | -$0.09 | -26.9% | $878,000 |
| May 14, 2025 | -$0.18 | -$0.08 | -125.0% | $1.3M |
| Mar 19, 2025 | -$0.04 | -$0.06 | +33.3% | $1.2M |
| Nov 14, 2024 | -$0.09 | -$0.08 | -12.5% | $953,000 |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (forward) | 45.2× | — | — | — |
| EV / Sales | 36.48× | — | — | Bottom 14% |
| Free-cash-flow yield | -3.80% | — | — | Top 48% |
| Earnings yield | -14.75% | — | — | Bottom 39% |
P/E over the past five years
Range 8.6× – 18.6× since Sep 30, 2022. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✓ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 80
- Days above the 200-day average
- 80
- 50-day average slope (20 days)
- +14.0%
- 200-day average slope (20 days)
- +8.2%
- Distance from 50-day average
- +9.4%
- Distance from 200-day average
- +54.1%
- RSI (14)
- 52.9
- Relative volume
- 2.01×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 60.4%
- Volatility vs own 5-year history
- 10th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.56
- Correlation with S&P 500
- 0.22
- Current drawdown from 1-year high
- -9.6%
- Maximum drawdown, 3 years
- -64.2%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Jan 4, 2021 | Dec 16, 2024 | -93.8% | 994 days | Not yet recovered |
| Oct 9, 2020 | Oct 26, 2020 | -27.9% | 11 days | 11 days (Nov 10, 2020) |
| Dec 14, 2020 | Dec 15, 2020 | -22.3% | 1 days | 3 days (Dec 18, 2020) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $3.04B
- EPS, diluted (TTM)
- -$1.14
- Revenue (TTM)
- $85.7M
- 52-week range
- $2.99 – $8.98
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $14.3M | $26.9M | $6.2M | $3.9M | $9.7M |
| Gross profit | -$39.4M | $20.6M | $106,000 | -$342,000 | $3.6M |
| Operating income | -$91.9M | -$75.7M | -$99.8M | -$135.0M | -$106.6M |
| Net income | -$92.2M | $28.3M | -$95.9M | -$126.2M | -$250.6M |
| EPS (diluted) | -$0.47 | -$0.40 | -$0.39 | -$0.47 | -$1.41 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $953,000 | $1.2M | $1.3M | $856,000 | $2.9M | $4.6M | $23.3M | $55.0M |
| Net income | -$24.0M | -$19.7M | -$54.2M | -$26.6M | -$146.3M | -$23.5M | -$7.9M | $20.1M |
| EPS (diluted) | -$0.09 | -$0.07 | -$0.18 | -$0.09 | -$1.10 | -$0.07 | -$0.03 | $0.05 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$55.8M | -$65.0M | -$66.9M | -$68.2M | -$87.8M |
| Capital expenditure | -$7.2M | -$4.9M | -$1.5M | -$8.6M | -$2.0M |
| Free cash flow | -$63.0M | -$70.0M | -$68.5M | -$76.8M | -$89.8M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $121.0M | $0 | $72.8M | $31.2M | $310,000 |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $38.2M
- Total assets
- $170.3M
- Total liabilities
- $126.7M
- Total debt
- $98.3M
- Net debt
- $82.0M
- Shareholders’ equity
- $43.6M
As of Jun 30, 2026 (filed Aug 4, 2026).
Short interest
- Shares sold short
- 42,278,237
- Days to cover
- 16.27
- Change vs previous report
- +0.2%
FINRA short interest, settlement date Sep 15, 2026.